Sources of diagnostic uncertainty for chronically psychotic cocaine abusers

Psychiatric Services

Volumn 49, Issue 5, 1998, Pages 684-690

  Shaner, Andrew ^a,e   Roberts, Lisa J ^a,b   Eckman, Thad A ^a   Racenstein, J Meg ^a,c   Tucker, Douglas E ^a,d   Tsuang, John W ^a   Mintz, Jim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ADULT; AMNESIA; ARTICLE; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 0031959550     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.49.5.684     Document Type: Article

References (37)

1. Drake RE, Rosenberg SD, Mueser KT: Assessing substance use disorder in persons with severe mental illness. New Directions for Mental Health Services, no 70:3-17, 1996
2. Lehman AF, Myers CP, Corty E: Assessment and classification of patients with psychiatric and substance abuse syndromes. Hospital and Community Psychiatry 40: 1019-025, 1989
3. Carey KB: Research with dual diagnosis patients: challenges and recommendations. Behavior Therapist 14:5-8, 1991
4. Decker KP, Ries RK: Differential diagnosis and psychopharmacology of dual disorders. Psychiatric Clinics of North America 16: 703-718, 1993
5. Shaner AL, Khalsa HK, Roberts L, et al: Unrecognized cocaine use among schizophrenics. American Journal of Psychiatry 150:758-761, 1993
6. Wilkins JN, Shaner AL, Patterson CM, et al: Discrepancies among patient report, clinical assessment, and urine analysis in psychiatric patients during inpatient admission. Psychopharmacology Bulletin 27:149-154, 1991
7. Connell PH: Amphetamine Psychosis. Maudsley Monographs, no 5. London, Oxford University Press, 1958
8. Satel SL, Southwick SS, Gawin FH: Clinical features of cocaine-induced paranoia. American Journal of Psychiatry 148:495-498, 1991
9. Bell DS: The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry 29:35-40, 1973
10. Angrist B, Sathananthan G, Wilk S, et al: Amphetamine psychosis: behavioral and biochemical aspects. Journal of Psychiatric Research 11:13-23, 1975
11. Hall RCW, Popkin MIK, Beresford TP, et al: Amphetamine psychosis: clinical presentations and differential diagnosis. Psychiatric Medicine 6:73-79, 1988
12. Griffith JD, Oates J, Cavanaugh J: Paranoid episodes induced by drugs. JAMA 205:39-46, 1968
13. Angrist B, Gershon S: The phenomenology of experimentally induced amphetamine psychosis: preliminary observations. Biological Psychiatry 2:95-107, 1970
14. Griffith JD, Cavanaugh J, Held J, et al: Dextroamphetamine: evaluation of psychotomimetic properties in man. Archives of General Psychiatry 26:97-100, 1972
15. Sherer MA: Intravenous cocaine: psychiatric effects, biological mechanisms. Biological Psychiatry 24:865-885, 1988
16. Flaum M, Schultz SK: When does amphetamine-induced psychosis become schizophrenia? American Journal of Psychiatry 153:812-815, 1996
17. Boutros NN, Bowers NM: Chronic substance-induced psychotic disorders: state of the literature. Journal of Neuropsychiatry 8:262-269, 1996
18. Janowsky DS, El-Yousef MK, Davis JM, et al: Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Archives of General Psychiatry 28:185-191, 1973
19. Janowsky DS, Davis JM: Methylphenidate, dextroamphetamine, and levamphetamine: effects on schizophrenic symptoms. Archives of General Psychiatry 33:304-308, 1976
20. Lucas PB, Pickar D, Kelsoe J, et al: Effects of the acute administration of caffeine in patients with schizophrenia. Biological Psychiatry 28:35-40, 1990
21. Kornetsky C: Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine. Archives of General Psychiatry 33:1425-1428, 1976
22. Angrist B, Rotrosen J, Gershon S: Differential effects of amphetamine and neuroleptics on negative and positive symptoms in schizophrenia. Psychopharmacology 72: 17-19, 1980
23. Van Kammen DP, Bunney WE Jr, Docherty JP, et al: d-Amphetamine induced heterogeneous changes in psychotic behavior in schizophrenia. American Journal of Psychiatry 139:997-999, 1982
24. Van Kammen DP, Boronow JJ: Dextro-amphetamine diminishes negative symptoms in schizophrenia. International Clinical Psychopharmacology 3:111-121, 1988
25. Dixon L, Haas G, Weiden PJ, et al: Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry 148:224-230, 1991
26. Gorelick DA: Alcohol and cocaine: clinical and pharmacological interactions, in Recent Developments in Alcoholism. Vol 19: Alcohol and Cocaine: Similarities and Differences. Edited by Galanter M. New York, Plenum, 1992
27. Landry MJ: An overview of cocaethylene, an alcohol-derived, psychoactive, cocaine metabolite. Journal of Psychoactive Drugs 24:273-276, 1992
28. Spitzer RL, Williams JBW, Gibbon M, et al: User's Guide for the Structured Clinical Interview for DSM-III-R. Washington, DC, American Psychiatric Press, 1990
29. Kraemer HC: Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, Calif, Sage, 1992
30. Cohen J: A coefficient of agreement for nominal scales. Educational and Psychological Measurement 20:37-46, 1960
31. Spitzer RL: Psychiatric diagnosis: are clinicians still necessary? Comprehensive Psychiatry 24:399-411, 1983
32. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, rev. Washington, DC, American Psychiatric Association, 1987
33. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
34. McLellan AT, Luborsky L, Woody GE, et al: An improved evaluation instrument for substance abuse patients: the Addiction Severity Index. Journal of Nervous and Mental Disease 168:26-33, 1968
35. Appleby L, Dyson V, Altman E, et al: Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population. Journal of Nervous and Mental Disease 185:159-165, 1997
36. Carey KB, Cocco KM, Correia CJ: Reliability and validity of the Addiction Severity Index among psychiatric outpatients. Psychological Assessment, in press
37. Bryant KJ, Rounsaville B, Spitzer RL, et al: Reliability of dual diagnosis: substance dependence and psychiatric disorders. Journal of Nervous and Mental Disease 180: 251-257, 1992